• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- NEWS BRIEFS August 8, 2023

L

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/news-briefs

Quick takes: Global flu declines, CEPI funding for disease X, more contaminated cannabis products


News brief

Today at 3:29 p.m.
Stephanie Soucheray, MA
Topics

Influenza, General

Pandemic Influenza

Salmonella

Foodborne Disease
  • The World Health Organization (WHO) published a new global flu update, and said many Southern Hemisphere countries are reporting declining activity following seasonal peaks in recent weeks. A few parts of the world are seeing elevated activity, including Bangladesh and the Maldives. Activity is below seasonal thresholds in the Northern Hemisphere. Globally, of samples tested during the middle 2 weeks of July, 72.2% were influenza A, and of subtyped A samples, 51.1% were 2009 H1N1.
  • Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced up to $3.6 million to support the development of Gennova Pharmaceutical's self-amplifying thermostable mRNA (saRNA) vaccine platform for developing measures against disease X. Disease X is a catch-all term for unknown pathogenic threats. Once developed, the saRNA-platform technology will be tested against rabies viruses in preclinical studies, which will help determine how successful this new technology can be. "To make sure the world has access to such technology quickly and equitably the next time Disease X strikes, CEPI is supporting novel RNA vaccine technologies with significantly improved attributes—in terms of scalability, thermostability, immunogenicity, and affordability—that could provide versatile platforms for rapid response against emerging infectious threats," said Melanie Saville, PhD, the executive director of vaccine research and development at CEPI.
  • For the second time this summer the Arizona Department of Health Services (ADHS) announced that a company has recalled its cannabis products due to Salmonella contamination found in lab tests. No humans have been sickened by these gummies, and the recall was voluntary. Earlier this summer, Arizona officials warned about Salmonella and Aspergillus contamination in a few live-resin concentrate and plant trim products, based on testing.
​
 
You must log in or register to reply here.
Back
Top Bottom